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Introduction

46
Cyclosporine A (CsA, Fig. 1 ), a lipophilic cyclopeptide consisting of eleven 47 amino acids, was first isolated from the soil fungus Tolypocladium inflatum (1). It is a 48 well-known immunosuppressant drug that has been widely used in organ 49 transplantation to prevent allograft rejection and in the treatment of autoimmune 50 diseases (2, 3). Despite of its immunosuppressant activity, CsA provokes several side 51 effects such as nephrotoxicity, hypertension and hirsutism (4, 5). Among these side 52 effects, the strong hair growth-stimulating activity of CsA has attracted significant 53 attentions from both academy and cosmetics industry due to its great potential to treat 54 alopecia (6, 7). Mechanistically, it was revealed that CsA stimulates the growth of Thus, thousands of actinomycete strains were screened to select Sebekia benihana 66 KCTC 9610 as the biotransformation strain, which is able to convert CsA into substrates to generate high value-added products (16).
79
The sequential transfer of two reducing equivalents from NAD(P)H to the 80 heme-iron reactive center of P450 enzymes via the delivery of redox partner system is 81 a key step in the P450 catalytic cycle. However, the optimal (either native or heterologous) redox partners often remain 94 unknown or difficult to express for many potential industrial P450s. Thus, it often 95 becomes necessary to construct hybrid P450 reaction systems by using surrogate 96 redox partner proteins in order to achieve desired catalytic processes (22).
97
For the P450 CsA hydroxylase CYP-sb21, seven putative fdx genes and four fdR 98 genes were mined from the whole genome of S. benihana (11). Each of these eleven 99 genes was individually inactivated using the PCR-targeted gene disruption system.
100
None of Fdxs and FdRs turned out to be CYP-sb21 specific. Although it was 101 implicated that Fdx-sb8 and FdR-sb3 might be the major redox partners for the 102 regio-specific CsA hydroxylation by CYP-sb21 in vivo, this has not been validated 103 since the expression system for these S. benihana redox proteins is not developed so 104 far.
105
In this study, we confirmed CYP-sb21 as the CsA- 
144
The gene encoding CYP-sb21 was amplified from pET28b-cyp-sb21-RhFRED using and pCDFDuet-sefdR-sefdx were co-transformed into E. coli resulting in the strain 165 W2. All above constructs (Table 2) were confirmed through DNA sequencing by
166
Sangon Biotech (Shanghai, China).
167
Protein purification
168
The constructed plasmid was transformed into Escherichia coli BL21 (DE3). The In vitro enzyme assays for CYP-sb21 activities
184
The standard reaction contained 10 μM CYP-sb21, 10 μM RhFRED or 10 μM
185
Fdx plus 10 μM FdR, 200 μM CsA (diluted from 20 mM stock solution in methanol),
186
1 mM NADPH in 100 μl of reaction buffer (50 mM NaH 2 PO 4 , 10% glycerol, pH 7.4).
187
Optionally, 5 U glucose dehydrogenase (GDH) and 20 mM glucose were added as an 
Statistical analysis
241
The t test was used to evaluate the significance of differences between groups.
242
Each experimental value was expressed as the mean ± standard deviation (S.D. (Fig. 2B) . Also, the surrogate redox partner proteins such as seFdx, seFdR and
253
RhFRED were expressed and purified as shown by SDS-PAGE analysis ( Fig. 2A) . The reconstitution of the in vitro activity of CYP-sb21 was initiated by using the 257 commercially available spinach redox partner proteins including spFdx/spFdR.
258
Unfortunately, this commonly used redox system failed to support the CYP-sb21 259 activity (Fig. 3A) . Since the previous in vivo study (11) Quantitatively, the conversion ratios were 25.0% and 17.3% for the CYP-sb21 272 reaction using seFdx/seFdR and RhFRED, respectively.
273
We also used the self-sufficient P450 enzymes CYP-sb21-RhFRED and
274
CYP-sb21-RhFRED-fdx to hydroxylate CsA. The CYP-sb21-RhFRED converted 275 9.4% CsA into CsA-4-OH, while CYP-sb21-RhFRED-fdx only marginally catalyzed 276 the same reaction (Fig. 3A) . 83.5% conversion of CsA was achieved (Fig. 3B) .
293
Whole-cell biotransformation
294
The whole-cell system has become increasingly important in industry. (w/v) CTAB (Fig. 4) coelicolor.
330
In this study, we were able to overexpress the codon-optimized cyp-sb21 gene in Rhodococcus-spinach RhFRED-fdx, the in vitro activity of CYP-sb21 was 335 reconstituted. The catalytic system comprising CYP-sb21/seFdx/seFdR showed the 336 highest production of CsA-4-OH (Fig. 3A) , while the commercially available 337 spFdx/spFdR did not support CYP-sb21 activity at all (Fig. 3A) . These results
338
highlight the significance of the selection of redox partners when reconstituting the 339 activity of a P450 enzyme (22). We also examined the catalytic activity of CYP-sb21 25.0% to 53.0% (Table 3) . However, this solubility problem was not completely from CsA to CsA-4-OH ( Fig. 3B and Fig. 4 ).
368
The in vitro enzymatic conversion is apparently more straightforward and 369 environmentally-friendly. However, it is not preferred by industrial application due to 370 the high cost on enzyme purification, low operational stability and sensitivity of 371 enzyme toward process conditions (37 high production yield, rapid growth cycle, and easier product recovery.
383
It has been well known that CTAB can make E. coli more porous, hence 
